Oyster Point Pharma, Inc.
OYSTDelisted Jan 3, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001720725
Oyster Point Pharma, Inc. was delisted on Jan 3, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 53 institutions reported holding it in 13F filings for Q4 2022, worth $189.4M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Oyster Point Pharma, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
OYST is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022
- Institutional holders
- 1
- −52 vs. Q4 2022
- Shares held
- 1
- −17.0M (−100.0%) vs. Q4 2022
- Total value
- $11
- −$189.4M (−100.0%) vs. Q4 2022
- New holders
- 0
- 0 more added
- Sold out
- 52
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OYST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $11 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $11 |
| Q3 2025 | 1 | $11 |
| Q2 2025 | 1 | $11 |
| Q1 2025 | 1 | $11 |
| Q4 2024 | 1 | $11 |
| Q3 2024 | 1 | $11 |
| Q2 2024 | 1 | $11 |
| Q1 2024 | 1 | $11 |
| Q4 2023 | 1 | $11 |
| Q3 2023 | 1 | $11 |
| Q2 2023 | 1 | $11 |
| Q1 2023 | 1 | $11 |
| Q4 2022 | 53 | $189.4M |
| Q3 2022 | 60 | $112.6M |
| Q2 2022 | 61 | $87.6M |
| Q1 2022 | 72 | $246.2M |
| Q4 2021 | 80 | $378.8M |
| Q3 2021 | 69 | $210.8M |
| Q2 2021 | 58 | $318.3M |
| Q1 2021 | 61 | $335.9M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Oyster Point Pharma, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $11 | 0.00% | −895−99.9% | Reduced |
| NEA Management Company, LLC | 0 | $0 | 0.00% | −5,925,287−100.0% | Sold out |
| Invus Financial Advisors, LLC | 0 | $0 | 0.00% | −2,768,586−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −2,304,977−100.0% | Sold out |
| Kohlberg Kravis Roberts & Co. L.P. | 0 | $0 | 0.00% | −1,039,622−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −655,044−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −651,051−100.0% | Sold out |
| GW&K Investment Management, LLC | 0 | $0 | 0.00% | −554,288−100.0% | Sold out |
| MMCAP International Inc. SPC | 0 | $0 | 0.00% | −515,491−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −319,524−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −221,476−100.0% | Sold out |
| Chicago Capital Management, LLC | 0 | $0 | 0.00% | −212,234−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −210,200−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −206,254−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −174,763−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −170,250−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −162,042−100.0% | Sold out |
| Gamco Investors, Inc. Et Al | 0 | $0 | 0.00% | −158,815−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −108,443−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −107,662−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −44,115−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −39,501−100.0% | Sold out |
| Wildcat Capital Management, LLC | 0 | $0 | 0.00% | −36,847−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −29,511−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −25,532−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,900−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −19,927−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −18,878−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −18,261−100.0% | Sold out |
| Equitec Proprietary Markets, LLC | 0 | $0 | 0.00% | −17,266−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −15,787−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −14,178−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −12,816−100.0% | Sold out |
| Coastal Bridge Advisors, LLC | 0 | $0 | 0.00% | −11,970−100.0% | Sold out |
| Crystalline Management Inc. | 0 | $0 | 0.00% | −11,421−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −11,375−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −11,057−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −8,861−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −7,986−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2,997−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,250−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −2,085−100.0% | Sold out |
| Freedom Wealth Alliance, LLC | 0 | $0 | 0.00% | −1,921−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,035−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −342−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |